N@N

ZGEN, INWK, SCR, LNY, ELMG, WPC Expected To Be Higher After Earnings Releases on Thursday

^{Published on 2009-11-02 11:35:17, Last Modified on 2010-12-22 17:26:42 - WOPRAI}
 

November 3, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, November 5th and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and November earnings reports. ZymoGenetics (NASDAQ: ZGEN), InnerWorkings (NASDAQ: INWK), Simcere Pharmaceutical (NYSE: SCR), Landrys (NYSE: LNY), EMS Technologies (NASDAQ: ELMG) and WP Carey (NYSE: WPC) are all expected to be higher after their earnings are released Thursday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go higher after earnings are released Thursday:

Symbol Company # of Reports Quarter Release Time

ZGEN ZymoGenetics, Inc. November earnings Q3 After

INWK InnerWorkings Inc 12 quarters Q3 After

SCR Simcere Pharmaceutical 12 quarters Q3 Before

LNY Landry's Restaurants 12 quarters Q3 Before

ELMG EMS Technologies Inc 12 quarters Q3 Before

WPC W.P. Carey & Co. LLC 12 quarters Q3 Before

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

ZymoGenetics, Inc. (NASDAQ: ZGEN), a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including hemostasis, inflammatory and autoimmune diseases, cancer, and viral infections. Its products include RECOTHROM, a recombinant thrombin, which is a topical hemostatic agent used for the control of moderate bleeding during surgical procedures. The companya�s product candidates in clinical development stages include PEG-IFN-l, a pegylated version of the IFN-l1 protein, which is in Phase Ib clinical trials for the treatment of viral infections and autoimmune diseases; IL-21 for the treatment of metastatic melanoma and metastatic renal cell carcinoma; IL-21 monoclonal antibody (mAb) to treat inflammatory diseases; and IL-31 mAb for the treatment of atopic dermatitis and inflammatory diseases. Its out-licensed product candidates include atacicept for the treatment of systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis; Augment Bone Graft for orthopedic fracture and other bone defects; rFactor XIII for congenital factor XIII deficiency, cardiac surgery, and cancer related bleeding; Fibroblast growth factor-18 for osteoarthritis; IL-17 receptor C for inflammatory diseases; and IL-20 and IL-22 receptor subunit alpha for psoriasis. The company also offers out-licensed commercial products comprising Novolin and insulin analogs for diabetes; NovoSeven for the treatment of hemophilia; Regranex for wound healing; GEM 21S for periodontal defects; GlucaGen for hypoglycemia and gastrointestinal motility inhibition; and Cleactor for treatment of myocardial infarction. ZymoGenetics has collaboration agreements with Bayer Schering Pharma AG; Bristol-Myers Squibb Company; and Merck Serono S.A. The company was founded in 1981 and is headquartered in Seattle, Washington.

InnerWorkings, Inc. (NASDAQ: INWK) provides managed print and promotional procurement solutions to corporate clients in the United States. It also procures, manages, and delivers printed products. The companya�s proprietary software applications and database, PPM4, create an integrated solution that stores, analyzes, and tracks the production of supplier network, as well as quotes and prices data for print jobs. The company offers its services for direct mail pieces, books, brochures, catalogues, point-of-purchase, displays, magazines, packaging, store fixtures, CDS/DVDS, promotional products, annual reports, envelopes, labels, calendars, folders, gift cards, signage, posters, newsletters, billboards, playing cards, binders, apparel, games, stationery, business and automobile wraps, postcards, stickers, bags, magnets, warehousing, and pick and pack. It offers fulfillment and logistics services, such as kitting and assembly, inventory management, and pre-sorting postage. The company, through its subsidiaries, provides print management services; and the procurement and production management of printed and promotional products and related warehousing and fulfillment functions. InnerWorkings, Inc. was founded in 2001 and is headquartered in Chicago, Illinois with additional offices in New York, New Jersey, California, Hawaii, Michigan, Minnesota, Texas, Pennsylvania, Georgia, Wisconsin, Missouri, and the United Kingdom.

Simcere Pharmaceutical Group (NYSE: SCR) engages in the research, development, manufacture, distribution, and marketing of branded generic pharmaceutical products in the Peoplea�s Republic of China. Its principal products include prescription edaravone injection for the treatment of strokes under the Bicun brand; amoxicillin capsules, dispersible tablets, granules, and injection under the brand Zailin; and generic diclofenac sodium, an anti-inflammatory pain reliever and analgesic drug to treat rheumatoid arthritis and osteoarthritis under the brand Yingtaiqing. The companya�s products also comprise sustained release implants under the Sinofuan brand for the treatment of cancer; edaravone injection under the Yidasheng brand for the treatment of strokes; anti-diarrhea pharmaceutical under the Biqi brand; cefaclor in dry suspension antibiotics under the Zake brand for the treatment of infections; and a herbal medicine used for the treatment of coughs under the Simcere Kechuanning brand name. In addition, it distributes prescription pharmaceuticals manufactured by independent third parties, including generic alfacalcidol soft capsules under the name Faneng, and generic lentinan injection under the brand Yineng. As of March 31, 2009, it also had 12 product candidates in various stages of development, including treatments for cancer, cerebrovascular diseases, infections, rheumatoid arthritis, nausea, and vomiting associated with chemotherapy. The company manufactures and sells 45 pharmaceuticals products and distributes 3 additional pharmaceuticals that are manufactured by independent third parties under the companya�s brand names. It has an agreement with Epitomics, Inc. for the co-development and production of humanized RabMAb antibody therapeutics for tumors. The company has a strategic partnership agreement with Sun Yat-Sen University Cancer Center. Simcere Pharmaceutical Group was founded in 1995 and is headquartered in Nanjing, the Peoplea�s Republic of China.

Landrys Restaurants, Inc. (NYSE: LNY), a restaurant, hospitality, and entertainment company, engages in the ownership and operation of full-service casual dining restaurants and gaming facilities in the United States and Canada. The company operates its restaurants under the names Rainforest Cafe, Saltgrass Steak House, Landrya�s Seafood House, The Crab House, Charleya�s Crab, and The Chart House. Its restaurant concepts include upscale steak and seafood restaurants, and casual theme-based restaurants. The company also owns and operates select hospitality businesses, including hotels, casino resorts, aquarium complexes, and the Kemah Boardwalk, a 40-acre amusement, entertainment, and retail complex in Kemah, Texas. In addition, it owns and operates the Golden Nugget Hotels and Casinos in downtown Las Vegas and Laughlin, Nevada. As of December 31, 2008, it owned and operated approximately 175 full-service and limited-service restaurants in 27 states and Canada. Landrya�s Restaurants, Inc. was founded in 1980 and is based in Houston, Texas.

EMS Technologies, Inc. (NASDAQ: ELMG) designs, manufactures, and markets wireless communications solutions for commercial and government users. The companya�s Defense & Space segment develops microwave-based hardware for use on satellites and in other defense electronics applications. Its products are used in commercial and civil ventures, including communications satellites and direct broadcast radio systems; and systems used for bringing satellite television signals to homes, automobiles, and to the seat backs of commercial airliners. This segment also offers research and development services directly for the U.S. Department of Defense. Its LXE segment designs, manufactures, and installs rugged mobile computers for use with wireless local area networks that enable customers to collect data and transact supply-chain execution events in real-time. This segment also provides hand-held and vehicle-mounted terminals, wireless networks, host connectivity software, and accessories, as well as maintenance services. The companya�s Satellite Communications segment designs and develops satellite-based communications, tracking, and messaging solutions. This segmenta�s products include aeronautical antennas and terminals for corporate aircrafts, government and military aircrafts, and commercial airlines; satellite packet data terminals for transportation, public safety, workforce automation, oil and gas remote monitoring and control, and force tracking applications; and emergency management products for rescue and mission control centers. The company serves the aeronautical, defense, maritime, commercial space, and auto-identification/data capture markets. It markets products directly to end-users, as well as to third parties, including strategic partners, value-added resellers, distributors, and independent marketing representatives in the United States and internationally. The company was founded in 1968 and is based in Norcross, Georgia.

W. P. Carey and Co. LLC (NYSE: WPC) is an investment management company. The firm also provides long-term net lease financing for companies. It manages real estate funds for its clients. The firm invests in real estate markets across the globe. It primarily invests in office, warehouse, industrial, distribution centers, retail, hotels, and R&D properties as well as manufacturing and special purpose facilities located in North America, Europe, and Asia. The firm also seeks to invest in the automotive, biotech, bottling, building products, distribution, education, food and beverage, general industrial, manufacturing, packaging, printing, retail, self storage, and technology sectors. Through its funds with synchronization with other companies and private equity firms, the firm provides investments to finance debt reduction, mergers and acquisition, leveraged and management buyout, corporate restructuring and exit financing, synthetic lease conversion, add-on acquisition, recapitalization, growth capital, and corporate refinancing transactions. W. P. Carey & Co. LLC was founded in 1973 and is based in New York, New York with additional offices in Dallas, Texas; London, United Kingdom; and Amsterdam, the Netherlands.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641